Vesiflo raises $2.4M toward $3M round to scale FDA-approved inFlow device that frees neurogenic bladder patients from catheters
Vesiflo, a Redmond medical device startup, has raised $2.4 million toward a $3 million round to manufacture and distribute its FDA-approved inFlow urethral device, which helps patients with neurogenic bladder urinate without catheters and reportedly reduces infections and improves quality of life.